As of 2025-10-17, the EV/EBITDA ratio of Silk Road Medical Inc (SILK) is -20.52. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SILK's latest enterprise value is 1,170.43 mil USD. SILK's TTM EBITDA according to its financial statements is -57.03 mil USD. Dividing these 2 quantities gives us the above SILK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.8x - 13.8x | 13.7x |
| Forward P/E multiples | 9.3x - 14.1x | 10.3x |
| Fair Price | (16.42) - (20.71) | (18.16) |
| Upside | -159.7% - -175.3% | -166.1% |
| Date | EV/EBITDA |